UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
Form 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event Reported): November 8, 2018
United-Guardian, Inc.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 001-10526 | 11-1719724 |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
| 230 Marcus Boulevard, Hauppauge, New York 11788 |
| (Address of Principal Executive Offices) (Zip Code) |
(631) 273-0900
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | ||
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 2.02. Results of Operations and Financial Condition.
On November 8, 2018, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| United-Guardian, Inc. | ||
| Date: November 8, 2018 | By: | /s/ Ken Globus |
| Ken Globus | ||
| President | ||
EXHIBIT 99.1
United-Guardian Reports Third Quarter Financial Results
HAUPPAUGE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported today that net income for both the third quarter and the first nine months of 2018 increased over the comparable periods in 2017, with third quarter net income rising from $1,090,323 ($0.24 per share) to $1,316,524 ($0.29 per share), and net income for the first nine months increasing from $2,828,907 ($0.62 per share) to $3,769,048 ($0.82 per share). Gross sales increased from $3,304,489 to $3,599,530 for the third quarter, and from $10,068,868 to $11,407,876 for the nine-month period.
Ken Globus, President of United-Guardian, stated, “With increased sales of our cosmetic ingredients, along with higher sales of Renacidin® Irrigating Solution, our most important pharmaceutical product, we have been able to maintain the steady increase in sales that we have experienced so far this year. Sales of our personal care products, in particular our Lubrajel® line of water-based moisturizers and lubricants, increased by 14% for the third quarter and 17% for the first nine months of the year, with sales to our largest marketing partner, Ashland Specialty Ingredients, increasing by 35% for the third quarter and 23% for the nine-month period. Those increases were partially offset by a reduction in sales to Korea, a situation that we are currently addressing. We remain optimistic that we will be able to continue to increase our sales by working closely with our marketing partners to expand the marketing of our current line of cosmetic ingredients, and by bringing to market some of the new cosmetic ingredients that are currently under development. Those efforts, along with our new web-based marketing efforts for Renacidin, should enable us to continue to increase our sales in the coming years.”
United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.
Contact: Robert S. Rubinger
Public Relations
(631) 273-0900
NOTE: This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.
| RESULTS FOR THE QUARTERS ENDED SEPTEMBER 30, 2018 and SEPTEMBER 30, 2017* STATEMENTS OF INCOME (UNAUDITED) | ||||||||||||
| THREE MONTHS ENDED SEPTEMBER 30, | NINE MONTHS ENDED SEPTEMBER 30, | |||||||||||
| 2018 | 2017 | 2018 | 2017 | |||||||||
| Sales: | ||||||||||||
| Gross sales | $ | 3,599,530 | $ | 3,304,489 | $ | 11,407,876 | $ | 10,068,868 | ||||
| Sales allowances and returns | (185,528 | ) | (126,697 | ) | (515,144 | ) | (329,937 | ) | ||||
| Net sales | 3,414,002 | 3,177,792 | 10,892,732 | 9,738,931 | ||||||||
| Costs and expenses: | ||||||||||||
| Cost of sales | 1,267,076 | 1,110,806 | 4,328,180 | 4,042,015 | ||||||||
| Operating expenses | 519,330 | 438,257 | 1,577,864 | 1,320,342 | ||||||||
| Research and development | 98,301 | 159,531 | 291,250 | 507,535 | ||||||||
| Total costs and expenses | 1,884,707 | 1,708,594 | 6,197,294 | 5,869,892 | ||||||||
| Income from operations | 1,529,295 | 1,469,198 | 4,695,438 | 3,869,039 | ||||||||
| Other Income (expense): | ||||||||||||
| Investment income | 38,048 | 64,054 | 142,607 | 185,616 | ||||||||
| Unrealized loss on marketable securities | (16,183 | ) | --- | (56,313 | ) | --- | ||||||
| Realized gain on marketable securities | 115,328 | 50,196 | 2,052 | 54,302 | ||||||||
| Loss on trade-in of equipment | --- | --- | (12,837 | ) | --- | |||||||
| Total other income (expense) | 137,193 | 114,250 | 75,509 | 239,918 | ||||||||
| Income before provision for income taxes | 1,666,488 | 1,583,448 | 4,770,947 | 4,108,957 | ||||||||
| Provision for income taxes | 349,964 | 493,125 | 1,001,899 | 1,280,050 | ||||||||
| Net income | $ | 1,316,524 | $ | 1,090,323 | $ | 3,769,048 | $ | 2,828,907 | ||||
| Earnings per common share (Basic and Diluted) | $ | 0.29 | $ | 0.24 | $ | 0.82 | $ | 0.62 | ||||
| Weighted average shares – basic and diluted | 4,594,319 | 4,594,319 | 4,594,319 | 4,594,319 | ||||||||
* Additional financial information can be found at the company’s web site at www.u-g.com.